神經血管用導管導引線的全球市場:規模，佔有率，趨勢分析(2023年～2029年):MedCore

全球神經血管用導管導引線的市場規模，2022年約2億2,000萬美金。該市場，預計在預測期間內以5.7％的年複合成長率擴大，達到3億2,000萬美元。

本報告提供全球神經血管用導管導引線市場相關調查，市場概要，以及各市場區隔，各地區趨勢，競爭情形等資訊。

目錄

神經血管用導管導引線市場

• 摘要整理
  • 全球神經血管用導管導引線市場概要
  • 競爭分析
  • 對像
• 簡介
• 市場分析與預測
• 促進因素與阻礙因素
  • 推動市場要素
  • 阻礙市場要素
• 競爭市場佔有率分析

The global market for neurovascular guidewire had a valuation of around $220 million in 2022, and it is projected to grow at a CAGR of 5.7% during the forecast period to reach $320 million. The complete report suite on the neurovascular guidewire market includes the analysis of neurovascular guidewires sold, average selling price, market value, and competitor market share.

MARKET REPORT DATA TYPES INCLUDED

Unit Sales, Average Selling Prices, Market Size & Growth Trends

COVID-19 Impact Analysis

Market Drivers & Limiters

Market Forecasts Until 2029, and Historical Data to 2019

Recent Mergers & Acquisitions

Company Profiles and Product Portfolios

Leading Competitors

GLOBAL NEUROVASCULAR GUIDEWIRE MARKET INSIGHTS

An increase in the number of endovascular procedures, particularly those utilizing liquid embolic, is driving the growth of the neurovascular guidewire market. This trend is expected to continue in the forecast period, resulting in a higher demand for guidewires. However, market growth may be hindered by certain complications related to the use of these devices.

GLOBAL NEUROVASCULAR GUIDEWIRE MARKET SHARE INSIGHTS

Within the global market for neurovascular guidewire, there are three key market players - Stryker, Scientia Vascular, and Medtronic. In 2022, Stryker was the leader in the global neurovascular guidewire market. The Synchro® has been a market leader since its launch. Additionally, Stryker sells the Transcend® product line of guidewires.

MARKET SEGMENTATION SUMMARY

Global Neurovascular Guidewire Market

RESEARCH SCOPE SUMMARY

Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)

Base Year: 2022

Forecast: 2023-2029

Historical Data: 2019-2022

Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.

Qualitative Coverage: COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.

Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

WHY CHOOSE IDATA?

Experts Only - iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.

Global Coverage - iData's unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.

Attention to Detail - It's our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.

Pricing - When comparing like-with-like, iData's prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.

TABLE OF CONTENT

TABLE OF CONTENTS

Neurovascular Guidewire Market

• 9.1 Executive Summary
  • 9.1.1 Global Neurovascular Guidewire Market Overview
  • 9.1.2 Competitive Analysis
  • 9.1.3 Regions Included
• 9.2 Introduction
• 9.3 Market Analysis and Forecast
• 9.4 Drivers and Limiters
  • 9.4.1 Market Drivers
  • 9.4.2 Market Limiters
• 9.5 Competitive Market Share Analysis

LIST OF CHARTS

LIST OF CHARTS:

• Chart 9-1: Neurovascular Guidewire Market, Global, 2022 & 2029
• Chart 9-2: Neurovascular Guidewire Units Sold, Global, 2022
• Chart 9-3: Neurovascular Guidewire Market, Global, 2019 - 2029
• Chart 9-4: Leading Competitors, Neurovascular Guidewire Market, Global, 2022

LIST OF FIGURES

LIST OF FIGURES

• Figure 9-1: Neurovascular Guidewire Regions Covered, Global (1 of 2)
• Figure 9-2: Neurovascular Guidewire Regions Covered, Global (2 of 2)
• Figure 9-3: Neurovascular Guidewire Market, Global, 2019 - 2029
• Figure 9-4: Units Sold by Region, Neurovascular Guidewire Market, Global, 2019 - 2029
• Figure 9-5: Average Selling Price by Region, Neurovascular Guidewire Market, Global, 2019 - 2029 (US$)
• Figure 9-6: Market Value by Region, Neurovascular Guidewire Market, Global, 2019 - 2029 (US$M)
• Figure 9-7: Leading Competitors, Neurovascular Guidewire Market, Global, 2022